Category: cannabidiol

WHO Report: No Public Health Problems Attributable To CBD

The use of the naturally occurring cannabinoid CBD is safe, well tolerated, and is not associated with any significant adverse public health effects, according to the findings of a preliminary report compiled by the World Health Organization’s Expert Committee on Drug Dependence. The agency is in the process of considering whether to place CBD within the agency’s international drug scheduling code.

DEA Reaffirms Stance That CBD Meets Schedule I Criteria — Reality Says Otherwise

The US Drug Enforcement Administration has publicly reiterated its position that cannabidiol, a non-psychotropic cannabinoid, is properly categorized under federal law as a schedule I controlled substance — meaning that, by definition, it possesses “a high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and lacks “accepted safety … under medical supervision.”

NORML’s Legislative Round Up July 15th, 2016

Members of Congress this week heard testimony on the state of marijuana research, and leading members of the US Senate introduced legislation to potentially reclassify CBD. A medical marijuana initiative in Montana qualified for the November ballot and Governors in three states signed marijuana related bills into law. Click here to get this week’s latest marijuana news and to find out how you can #TakeAction.

Study: CBD Oil “Highly Promising” In Pediatric Epilepsy Treatment

The administration of cannabis oil extracts high in cannabidiol reduces seizure frequency in children with intractable epilepsy, according to clinical data published online ahead of print in the journal Seizure. Investigators reported: “CBD treatment yielded a significant positive effect on seizure load. Most of the children (89 percent) reported reduction in seizure frequency. … In addition, we observed improvement in behavior and alertness, language, communication, motor skills and sleep.”

Study: Oral Cannabis Extracts Associated With Seizure Control In Children With Treatment-Resistant Epilepsy

The administration of oral cannabis extracts is associated with the mitigation of seizures in adolescents with epilepsy, according to clinical data published this month in the journal Epilepsy & Behavior. Authors reported that 57 percent of subjects showed some level of improvement in seizure control while 33 percent reported a greater than 50 percent reduction in seizure frequency.